Termination by Celldex Clause Samples
The 'Termination by Celldex' clause grants Celldex the explicit right to end the agreement under specified circumstances. Typically, this clause outlines the conditions under which Celldex may exercise this right, such as breach of contract by the other party, insolvency, or failure to meet certain milestones. By clearly defining when and how Celldex can terminate the agreement, this clause provides a mechanism for Celldex to manage risk and exit the contract if necessary, ensuring flexibility and protection for their interests.
Termination by Celldex. Should Celldex elect to terminate the Research Program for all Research Antigens without obtaining an Exclusive Commercial License pursuant to Section 4.3, this Agreement shall immediately terminate, in accordance with the terms of Section 13.4, upon thirty (30) days from the date of Medarex’s receipt of written notice from Celldex of such election.
Termination by Celldex. This Agreement may be terminated, in whole or on a Service-by-Service basis, for any reason by Celldex at any time during the term of the Agreement on thirty (30) days' prior written notice to Medarex; provided, however, that Celldex may not, pursuant to this Section 4.2, terminate this Agreement or a Service that is subject to a Service Provision Form then in effect without the prior written consent of Medarex, such consent not to be unreasonably withheld. Any termination of one or more of the Services will not affect the obligations of Medarex under this Agreement with respect to any other Services.
Termination by Celldex. Celldex shall have the right to terminate this Agreement (for other than default or breach by Prologue) or any Statement of Work attached to this Agreement at any time by giving appropriate written notice at least sixty (60) days prior to the desired termination date.
Termination by Celldex. Celldex shall have the right at any time to terminate this license in whole or as to any portion of the Licensed Assets by giving ninety (90) days’ advance notice in writing to Duke; provided however, that Celldex’s obligations under Article 4 shall survive any such partial termination for any portion of the Licensed Assets that have not been terminated.
Termination by Celldex. Celldex may terminate this Agreement (i) upon one hundred and twenty (120) days prior written notice to Amgen (which written notice shall be dated no earlier than the first anniversary of the Effective Date), or (ii) upon ninety (90) days prior written notice to Amgen, due to a Safety Concern. If Celldex elects to terminate this Agreement pursuant to Section 10.4 (ii), Celldex shall promptly provide Amgen written details of such Safety Concern.